Last reviewed · How we verify
NCT06168344
The Effect of Web-based Training Given to Mothers of Babies With Congenital Heart Disease
NA trial testing Web-Based Education Program in Mothers in 60 participants. Completed in 15 August 2023.
15 August 2023
Quick facts
| Lead sponsor | Saglik Bilimleri Universitesi |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 60 |
| Start date | 1 February 2022 |
| Primary completion | 15 August 2023 |
| Estimated completion | 15 August 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Web-Based Education Program
Conditions studied
- Mothers — all drugs for Mothers →
- Quality of Life — all drugs for Quality of Life →
- Self Efficacy — all drugs for Self Efficacy →
- Training — all drugs for Training →
Sponsor
Saglik Bilimleri Universitesi — full company profile →
Who can join
Under 12 Months, any sex, with Mothers or Quality of Life. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was assessed the impact of a web-based education program provided to mothers of infants with congenital heart diseases on their quality of life and self-efficacy levels. The study is a mixed-method approach with a qualitative and pre-test post-test design, utilizing randomized controlled quasiexperimental type. The research was conducted with mothers of infants diagnosed with congenital heart disease who sought care at the Pediatric Cardiology Outpatient Clinic of a university hospital and were followed up. There are two groups in the study. Web-based education was provided to mothers in the intervention group (n=30). No intervention was applied to the mothers in the control group (n=30) other than the outpatient clinic routine of the hospital.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The molecular mechanisms of cardiac development and related diseases.
Li Y, Du J, Deng S, Liu B, et al · · 2024 · cited 53× · PMID 39715759 · DOI 10.1038/s41392-024-02069-8
Verify or expand the search:
- PubMed search for NCT06168344
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Web-Based Education Program
Trials testing the same drug.
- NCT06605274 — Effectiveness Web-based Training on Perinatal Loss · NA · completed
Other recruiting trials for Mothers
Currently open trials in the same condition.
- NCT06999928 — Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIV · NA · recruiting
- NCT06917417 — The Effect of Laughter Therapy on Marital Adjustment, Life Satisfaction and Maternal Attachment Level in Mothers · NA · recruiting
- NCT06371469 — Program of Health Behaviour Against to Cancer (PHeBAC) · NA · recruiting
Other Saglik Bilimleri Universitesi trials
Trials by the same sponsor.
- NCT07499986 — Respiratory Muscle Training in Patients Undergoing Lung Cancer Surgery · NA · not yet recruiting
- NCT07516340 — Gamification-Based Peer Education in Nursing Students: Effects on Sexual Health Literacy and Attitudes · NA · not yet recruiting
- NCT07520435 — Short-Term Mindfulness Intervention for Anxiety and Maternal Attachment in NICU Mothers · NA · not yet recruiting
- NCT07528001 — Hypno-Breastfeeding Education and Postpartum Outcomes · NA · not yet recruiting
- NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06168344 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Saglik Bilimleri Universitesi
- Last refreshed: 13 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06168344.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing